PRECLINICAL DRUG STUDIES UNIT A
cod. 1000213

Academic year 2007/08
1° year of course - Second semester
Professor
Academic discipline
Farmacologia (BIO/14)
Field
Discipline farmaceutiche
Type of training activity
Characterising
10 hours
of face-to-face activities
1 credits
hub: -
course unit
in - - -

Integrated course unit module: BIOTECHNOLOGICAL DRUGS

Learning objectives

<div align="justify">To provide knowledge of the aims and methodologies adopted for preclinical safety evaluation of drugs, with particular reference to biotechnology-derived pharmaceuticals</div>

Prerequisites

<div align="justify">Basi molecolari dell'azione dei farmaci</div>

Course unit content

<p>Safety assessment of biotechnology-derived pharmaceuticals:<br />
</p>
<ol>
<li>Single-dose and repeated-dose toxicity studies</li>
<li>Reproductive and developmental, genotoxicity and carcinogenicity toxicity studies</li>
<li>Safety pharmacology</li>
</ol>
<p>Examples of preclinical studies of biotechnology-derived pharmaceuticals.<br />
</p>

Full programme

- - -

Bibliography

<div align="justify">Ballantyne B., Marrs T.C. General and applied toxicology. London, MacMillan (1993).<br />
Klaassen C. Casarett and Doull’s toxicology. McGraw-Hill Italia (2001).<br />
</div>

Teaching methods

- - -

Assessment methods and criteria

- - -

Other information

- - -